Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Day One Biopharmaceuticals (DAWN) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Q3 2025 value amounting to -$0.19.

  • Day One Biopharmaceuticals' EPS (Basic) fell 15000.0% to -$0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 4757.28%. This contributed to the annual value of -$2.2 for FY2024, which is 735.5% up from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported EPS (Basic) of -$0.19 as of Q3 2025, which was down 15000.0% from -$0.29 recorded in Q2 2025.
  • Over the past 5 years, Day One Biopharmaceuticals' EPS (Basic) peaked at $0.38 during Q3 2024, and registered a low of -$0.72 during Q1 2024.
  • Over the past 3 years, Day One Biopharmaceuticals' median EPS (Basic) value was -$0.44 (recorded in 2023), while the average stood at -$0.37.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 17037.04% in 2024, then tumbled by 48000.0% in 2025.
  • Day One Biopharmaceuticals' EPS (Basic) (Quarter) stood at -$0.64 in 2023, then fell by 10.15% to -$0.7 in 2024, then surged by 73.05% to -$0.19 in 2025.
  • Its last three reported values are -$0.19 in Q3 2025, -$0.29 for Q2 2025, and -$0.35 during Q1 2025.